- Home
- LWAY vs PALI Comparison
LWAY vs PALI Comparison
Compare LWAY & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LWAY | PALI |
|---|---|---|
| Founded | 1986 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 347.2M | 240.2M |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | LWAY | PALI |
|---|---|---|
| Price | $22.11 | $1.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $35.00 | $15.00 |
| AVG Volume (30 Days) | 48.1K | ★ 4.6M |
| Earning Date | 03-13-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $204,069,000.00 | N/A |
| Revenue This Year | $15.23 | N/A |
| Revenue Next Year | $13.72 | N/A |
| P/E Ratio | $29.76 | ★ N/A |
| Revenue Growth | ★ 12.14 | N/A |
| 52 Week Low | $19.50 | $0.53 |
| 52 Week High | $34.20 | $2.64 |
Technical Indicators
Market Signals| Indicator | LWAY | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 46.87 | 49.72 |
| Support Level | $21.25 | $1.65 |
| Resistance Level | $22.50 | $1.84 |
| Average True Range (ATR) | 0.64 | 0.13 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 40.61 | 77.50 |
Price Performance
Historical ComparisonAbout LWAY Lifeway Foods Inc.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.